A novel vaccine formulation utilizing trehalose to stabilize it as a powder has successfully completed initial human trials. This breakthrough aims to eliminate the need for refrigeration, thereby reducing the significant cold-chain waste that currently spoils approximately half of all vaccines produced. Future plans include a larger trial, with a potential rollout in Africa where vaccination rates are particularly low. AI
RANK_REASON The item describes the results of human trials for a new vaccine formulation, which falls under research. [lever_c_demoted from research: ic=1 ai=0.1]
Read on Mastodon — fosstodon.org →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
